通过小分子抑制剂对人类Gαi3蛋白进行分子识别研究的综合NMR结晶学计算方法
Mariola Ferreras-Gutiérrez1, Marina Mínguez-Toral1, Alain Ibáñez de Opakua2
1Centro de Investigaciones Biológicas Margarita Salas (CIB), CSIC, Madrid 28040, Spain.
International journal of biological macromolecules
|December 20, 2024
概括
小分子IGGi-11通过破坏Gαi蛋白相互作用来抑制癌症转移. 对IGGi-11的修改
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 异构三元核酸结合蛋白 (G蛋白) 和它们的子单元,如Gαi,在细胞信号通路中至关重要.
- G蛋白结合受体 (GPCR) 通过细胞外刺激激活Gα亚单元,而GIV等细胞内蛋白质也调节Gα亚单元活性.
- 升高的GIV水平与细胞迁移和癌症转移的增加有关,突出显示GIV是潜在的治疗点.
研究的目的:
- 研究小分子IGGi-11与Gαi子单元相互作用的分子机制.
- 为指导针对Gαi蛋白的新型,高亲和度抑制剂的设计,用于潜在的抗转移药物开发.
- 阐明IGGi-11与Gαi3结合的结构基础,并确定增强抑制剂疗效的策略.
主要方法:
- 利用核磁共振 (NMR) 来识别Gαi3中的灵活残留物,用于蛋白质结晶.
- 采用计算对接和分子动力学模拟来预测IGGi-11和Gαi3.3之间的结合相互作用.
- 分析了IGGi-11的结合特性,并指出其与GIV相比对Gαi3的竞争性抑制和差异性亲和力.
主要成果:
- IGGi-11 破坏了 Gαi 蛋白和 GIV 之间的相互作用,抑制了转移性乳腺癌细胞中的亲侵入性特征,而不影响 GPCR 信号传递.
- 用IGGi-11对Gαi3的结晶试验没有产生结合化合物的晶体.
- 计算建模揭示了IGGi-11与Gαi3的异质结合,这归因于分子的对称性以及结合部位的形状和灵活性.
结论:
- 这项研究提供了IGGi-11对Gαi3的分子识别的见解,尽管在获得直接结构数据方面存在挑战.
- 这些发现表明,修改IGGi-11的化学结构以打破其对称性可能会导致更高亲和度的抑制剂.
- 这些增强抑制剂有可能成为抗癌转移的新型治疗剂.
关键词:
晶体学 晶体学是指结晶学.停靠对接 停靠对接一个有趣的故事.IGGi-11 IGGi-11 - - 这是一本书.分子动力学模拟的模拟.分子识别分子识别这就是NMR的NMR.结构 结构 是一个结构.更多相关视频
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
13.6K
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
8.4K
相关概念视频
G Protein-coupled Receptors
11.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.3K
Activation and Inactivation of G Proteins
6.7K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.7K
G-protein Coupled Receptors
115.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
115.9K
Transducer Mechanism: G Protein–Coupled Receptors
1.8K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.8K
